Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME)

KalVista Investigative Site, Lynbrook

KalVista Investigative Site, Rochester

KalVista Investigative Site, Charlottesville

KalVista Investigative Site, Marietta

KalVista Investigative Site, Augusta

KalVista Investigative Site, Pensacola

KalVista Investigative Site, Miami

KalVista Investigative Site, Miami

KalVista Investigative Site, Winter Haven

KalVista Investigative Site, Fort Myers

KalVista Investigative Site, Cincinnati

KalVista Investigative Site, Indianapolis

KalVista Investigative Site, Rapid City

KalVista Investigative Site, Dallas

KalVista Investigative Site, Arlington

KalVista Investigative Site, Fort Worth

KalVista Investigative Site, San Antonio

KalVIsta Investigative Site, Austin

KalVista Investigative Site, Abilene

KalVista Investigative Site, Golden

KalVista Investigative Site, Phoenix

KalVista Investigative Site, Phoenix

KalVista Investigative Site, Tucson

KalVista Investigative Site, Henderson

KalVista Investigative Site, Beverly Hills

KalVista Investigative Site, Arcadia

KalVista Investigative Site, Palm Desert

KalVista Investigative Site, Santa Ana

KalVista Investigative Site, Tustin

KalVista Investigative Site, Palo Alto

KalVista Investigative Site, Sacramento

KalVista Investigative Site, Silverdale

KalVista Investigative Site, Boston

KalVista Investigative Site, Boston

KalVista Investigative Site, San Antonio